Antiestrogens: Studies using an in vitro estrogen-responsive uterine system

Benita S Katzenellenbogen, John A. Katzenellenbogen

Research output: Contribution to journalArticle

Abstract

Three antiestrogens have been tested in vitro for their capacity to affect the cytosol binding and nuclear uptake of 17β-estradiol (E2) and induction of the synthesis of a specific uterine protein (IP). CI-628 competes with E2 for binding sites, inhibits IP induction, and is itself much less effective than E2 in promoting the IP response; U-11, 100A is a binding competitor and a weak inducer of IP synthesis, but does not antagonize the E2-induced IP response. Dimethylstilbestrol is an effective inhibitor of E2 binding, elicits a high IP response, but does not antagonize E2-induced IP synthesis. Higher concentrations of antiestrogens are required to inhibit nuclear binding of E2 than expected from their relative binding ability to cytosol.

Original languageEnglish (US)
Pages (from-to)1152-1159
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume50
Issue number4
DOIs
StatePublished - Feb 20 1973

Fingerprint

Estrogen Receptor Modulators
Cytosol
Nitromifene
Nafoxidine
Estrogens
Estradiol
Binding Sites
Proteins
In Vitro Techniques
dimethylstilbestrol

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Antiestrogens : Studies using an in vitro estrogen-responsive uterine system. / Katzenellenbogen, Benita S; Katzenellenbogen, John A.

In: Biochemical and Biophysical Research Communications, Vol. 50, No. 4, 20.02.1973, p. 1152-1159.

Research output: Contribution to journalArticle

@article{f95dfbae86db4c088ea6172b4aae52dc,
title = "Antiestrogens: Studies using an in vitro estrogen-responsive uterine system",
abstract = "Three antiestrogens have been tested in vitro for their capacity to affect the cytosol binding and nuclear uptake of 17β-estradiol (E2) and induction of the synthesis of a specific uterine protein (IP). CI-628 competes with E2 for binding sites, inhibits IP induction, and is itself much less effective than E2 in promoting the IP response; U-11, 100A is a binding competitor and a weak inducer of IP synthesis, but does not antagonize the E2-induced IP response. Dimethylstilbestrol is an effective inhibitor of E2 binding, elicits a high IP response, but does not antagonize E2-induced IP synthesis. Higher concentrations of antiestrogens are required to inhibit nuclear binding of E2 than expected from their relative binding ability to cytosol.",
author = "Katzenellenbogen, {Benita S} and Katzenellenbogen, {John A.}",
year = "1973",
month = "2",
day = "20",
doi = "10.1016/0006-291X(73)91526-X",
language = "English (US)",
volume = "50",
pages = "1152--1159",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Antiestrogens

T2 - Studies using an in vitro estrogen-responsive uterine system

AU - Katzenellenbogen, Benita S

AU - Katzenellenbogen, John A.

PY - 1973/2/20

Y1 - 1973/2/20

N2 - Three antiestrogens have been tested in vitro for their capacity to affect the cytosol binding and nuclear uptake of 17β-estradiol (E2) and induction of the synthesis of a specific uterine protein (IP). CI-628 competes with E2 for binding sites, inhibits IP induction, and is itself much less effective than E2 in promoting the IP response; U-11, 100A is a binding competitor and a weak inducer of IP synthesis, but does not antagonize the E2-induced IP response. Dimethylstilbestrol is an effective inhibitor of E2 binding, elicits a high IP response, but does not antagonize E2-induced IP synthesis. Higher concentrations of antiestrogens are required to inhibit nuclear binding of E2 than expected from their relative binding ability to cytosol.

AB - Three antiestrogens have been tested in vitro for their capacity to affect the cytosol binding and nuclear uptake of 17β-estradiol (E2) and induction of the synthesis of a specific uterine protein (IP). CI-628 competes with E2 for binding sites, inhibits IP induction, and is itself much less effective than E2 in promoting the IP response; U-11, 100A is a binding competitor and a weak inducer of IP synthesis, but does not antagonize the E2-induced IP response. Dimethylstilbestrol is an effective inhibitor of E2 binding, elicits a high IP response, but does not antagonize E2-induced IP synthesis. Higher concentrations of antiestrogens are required to inhibit nuclear binding of E2 than expected from their relative binding ability to cytosol.

UR - http://www.scopus.com/inward/record.url?scp=0015930569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015930569&partnerID=8YFLogxK

U2 - 10.1016/0006-291X(73)91526-X

DO - 10.1016/0006-291X(73)91526-X

M3 - Article

C2 - 4347895

AN - SCOPUS:0015930569

VL - 50

SP - 1152

EP - 1159

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -